Abstract

Study design and methodsIn order to determine the therapeutic effect and mechanism of paeonol on acute kidney injury induced by endotoxin, an acute kidney injury model was established by intraperitoneal administration of lipopolysaccharide in mice in vivo and on LPS-induced dendritic cells in vitro. Renal tissues were used for histologic examination. Concentrations of blood urea nitrogen and serum creatinine were detected, inflammatory cytokines were determined by ELISA. The relative proteins' expression of TLR4-NF-κB signal pathway was assessed by Western blot, the localization and expression of phospho-NF-κB p65 in kidney was monitored by immunohistochemistry.ResultsTreatment of paeonol successfully cuts histopathological scores and dilutes the concentrations of blood urea nitrogen and serum creatinine as index of renal injury severity. In addition, paeonol reduces pro-inflammatory cytokines and increases anti-inflammatory cytokines stimulated by LPS in a dose-dependent manner. Paeonol also inhibits the expression of phosphorylated NF-κB p65, IκBα and IKKβ, and restrains NF-κB p65 DNA-binding activity. Paeonol treatment also attenuates the effects of LPS on dendritic cells, with significant inhibition of pro-inflammatory cytokines release, then TLR4 expression and NF-κB signal pathway have been suppressed.ConclusionsThese results indicated that paeonol has protective effects on endotoxin-induced kidney injury. The mechanisms underlying such effects are associated with its successfully attenuate inflammatory and suppresses TLR4 and NF-κB signal pathway. Therefore, paeonol has great potential to be a novel and natural product agent for treating AKI or septic-AKI.

Highlights

  • Acute kidney injury (AKI), as acute renal failure (ARF), is clinically defined as an abrupt and reversible dete­rioration of glomerular and tubular function

  • Paeonol reduces pro-inflammatory cytokines and increases anti-inflammatory cytokines stimulated by LPS in a dose-dependent manner

  • Paeonol inhibits the expression of phosphorylated nuclear factor-κB (NF-κB) p65, IκBα and IKKβ, and restrains NF-κB p65 DNA-binding activity

Read more

Summary

Introduction

Acute kidney injury (AKI), as acute renal failure (ARF), is clinically defined as an abrupt and reversible dete­rioration of glomerular and tubular function. Supportive renal replacement therapy is the only treatment option available for AKI, but the observed mortality for the more serious end of the spectrum of AKI remains high in the range of 50–60% when supported by RRT [5]. This observed mortality has hardly changed in recent decades despite advances in renal support technology [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call